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Abstract: The relationship between drug use and aggressive behaviour and its 
consequences on social and financial burden on society is a source of recent 
concern. This study, therefore, examined the effects of acute exposure to Codeine 
and Tramadol on aggressive behaviour. Twenty-Eight (28) participants (Female 
Albino Rats) weighing between 120-150g and 4-6 weeks old, collected from the 
University of Ibadan Veterinary animal farm were used for this study. They were 
divided into 5 experimental groups of Codeine, Tramadol, combined Codeine and 
Tramadol, Control and intruder groups with 6 rats in each group except the 
intruder group with 4 rats. They were exposed to, 8mg/kg of codeine for the 
codeine group, 20mg/kg of tramadol for the tramadol group, combined 8mg/kg of 
codeine and 20mg/kg of tramadol for the combined group, normal saline for the 
control group and no treatment for the intruder group for 28 days.  The rats were 
observed daily after treatment for, biting, dominant posture and scratching as 
attributes of aggressive behaviour. Randomized block ANOVA showed a 
significant effect of Codeine and Tramadol on aggressive behaviour among female 
albino rats, F (3,2010) = 53.53, p < 0.001, η2= .07. Female albino rats in the 
tramadol treatment group significantly exhibited more aggression (x ̅= 14.08) than 
control group (x ̅=11.53) codeine group (x ̅=11.41) and combined group (x ̅=7.36). 
The mean differences were significant (p<.001). It was concluded that chronic 
exposure to tramadol has implications for aggressive tendencies and combined 
exposure to tramadol and codeine may be injurious to health. 
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Introduction 
The concern over social violence and 
aggression among young and old in 
many countries around the world 
cannot be overemphasized. More 
worrisome is the manifestations of 
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aggressive traits and violence among 
young adults and adolescents in 
colleges and higher institutions. 
Consequently, the frequent news of gun 
violence, police brutality, political 
violence, domestic abuse, resistance to 
police authorities, homicides and 
murder, and a host of behaviours 
associated with aggression or its 
tendencies are common in many 
societies.  
 
Violence and aggressive behaviour are 
common terms used interchangeably. 
However, Eichelman (1992), in an 
attempt to draw a line between 
aggression and violent behaviour noted 
that there is ongoing confusion 
between the terms aggressive and 
violent behaviour. For this paper, the 
term violence specifically will be used 
to delineate behaviours motivated by 
the goal of the infliction of physical 
harm to others. Aggression, according 
to many authors is not a unitary 
behaviour but a constellation of 
adaptive behaviours that are amenable 
to topological classification and 
neurobiological manipulations (Brain 
and Al-Maliki, 1978, Valzelli, 1981).  
According to Moyer (1968) ethological 
framework, aggression is classified into 
the following classes, which highlight 
its adaptive character:  
 
(1)  Predatory aggression which is 
produced by hunger and the 
presence of an object of prey,  
(2)  Competitive aggression which 
involves fighting for dominance, 
social rank, and reproductive 
advantage.  
(3)   Defensive or fear-induced 
aggression which occurs in 
response to an inescapable 
threat,  
(4)  Irritative aggression which occurs 
in response to internal or 
external aversive stimuli in the 
absence of a significant fear 
component,  
(5) Territorial aggression is triggered 
by threats of intrusion into 
regions of established living 
activities,  
(6) Maternal aggression is 
characteristic of female animals 
defending their offspring against 
real or perceived threats,  
(7) Instrumental aggression is a 
learned behaviour reinforced by 
environmental contingencies. 
 
Thus, aggression may be thought of as 
a complex behaviour that is highly 
specific to situational demands. It may 
be difficult to be reduced to one 
predictable construct. Also, the 
pharmacologic effects of a 
psychoactive substance are likely to 
connect directly and indirectly to the 
expression of these behaviours in a 
complex fashion. In nature, aggression 
can occur without violence like the 
aggressive displays of some animals, 
whereas violence, defined as behaviour 
motivated by the desire to physically 
harm another, almost always occurs 
within the context of aggression and is 
consequently synonymous with the 
concept of violent aggression.  
 
Although the above definitions provide 
a framework in which to conceptualize 
aggression, the specific method by 
which it can be measured was not 
discussed. There are various 
approaches in the literature on how the 
measurement of aggression can be 
achieved and they vary widely. Some 
of the methods used by some studies 
include self-report scales of aggression, 
such as the Buss–Perry Aggression 
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Questionnaire (Buss & Perry, 1992), 
the State-Trait Anger Inventory 
(Spielberger, Jacobs, Russell, & Crane 
(1983) and the Novaco Anger and 
Provocation Inventory (Novaco, 2003) 
and others use behavioural measures, 
like the Competitive Reaction Time 
Task (Epstein & Taylor, 1967) and the 
Point Subtraction Aggression Paradigm 
(Cherek, 1981, 1992). Others still use a 
combination of self-report and 
behavioural aggression measures, of 
which there are over 200 (Ronan, 
Dreer, Maurelli, Ronan, & Gerhart, 
2013). In animal studies, aggression is 
often operationalized using the resident 
intruder test (Miczek, 1979) or direct 
attack-related behaviours.  
 
It is commonly known that using drugs 
can increase paranoid and irrational 
thoughts, mood swings, 
and irritability, amongst many other 
side effects (Chermack, Grogan-
Kaylor, Perron, Murray, De Chavez, & 
Walton, 2010).    Over time, drugs have 
been linked to anger and aggression. 
Drugs have either been used to 
alleviate uncomfortable emotional 
states or have been implicated in the 
precipitation of anger and aggression. 
Not only do many of the mood-altering 
substances impair perception but also 
there is proof that drugs, through their 
ability to alter neurotransmitter levels 
alter mood state (Chermack, et al., 
2010). Generalizations about the 
linkage of drugs of abuse and violence 
are complicated by the direct and 
indirect levels of interaction 
(Goldstein, 1985). These include drugs 
activating aggression-specific brain 
mechanisms; drugs acting as a reason 
for indulgent in violent and aggressive 
behaviour; and violent behaviour 
representing how a drug habit is 
maintained and preserved. 
 
Research has implicated several 
psychological characteristics to have a 
direct link to the risk of substance 
abuse. These behavioural 
characteristics include aggression  
hyperactivity, impulsivity (McCord and 
McCord,1960; Hechunan, Weiss, & 
Perlrnan, 1984), antisocial behaviour 
(Robins, 1966; Whitesell, Bachand, 
Peel, and Brown, (2013)), a dis-
inhibitory motivational state 
(Gorenstien and Newman, 1980), and 
deviant temperament (Tarter, Kabene, 
Escallier, 1990), all of which may 
involve poor regulation of aggressive 
impulses. 
 
Aggressive behaviour and drug use 
among humans have frequently been 
linked together (Pihl & Sutton, 2009). 
Research studies have shown that 
individuals who engage in both drug 
use and display of aggressive 
behaviour are more likely to be 
irresponsible, put themselves and 
others at risk, and are entangled in the 
legal system which all amount to a 
significant social problem 
(Hammersley, 2011). There is an 
ongoing and increasing serious concern 
on the relationship between drug use 
and aggressive behaviour (Hoaken, 
Hamill, Ross, Hancock, Lau, & 
Tapscott 2012). The relationship 
between drug use and aggression as 
well as other antisocial behaviours 
have generated a wealth of research 
majorly because of the social and 
financial costs on the society. Evidence 
supporting the link between drug use 
and aggression, antisocial behaviour, 
and crime has been mounting since the 
1930s (East, 1939). Evidence are in the 
comprehensive reviews of this 
relationship which have been 
periodically published since then 
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(Boles & Miotto, 2003; Brady, Myrick, 
& McElroy, 1998; Hoaken & Stewart, 
2003; Moss & Tarter, 1993; Nurco, 
Hanlon, & Kinlock, 1991). 
 
Overall, the literature suggests that the 
relationship between drugs and 
aggression is highly complex and is 
governed by a combination of both 
transient and permanent physiological, 
environmental, and individual 
differences factors. Although multiple 
factors are associated with the 
relationship between drug use and 
aggression, substantial research has 
been devoted to isolating specific 
factors such as physiological (Julien, 
2003; Lee, Schroeder, Karschner, 
Goodwin, Hirvonen, Gorelick,  & 
Huestis, 2014; Hoaken and Pihl, 2000; 
McCann, Szabo, Scheffel, Dannals, & 
Ricaurte,1998; Neal & Fromme, 2007; 
Smith, Homish, Leonard, & Collins, 
2013), the individual difference 
(Giancola, Godlaski, and Parrott, 2005; 
Parrott, 2007; Krueger, Markon, 
Patrick, Benning, & Kramer, 2007; 
Moeller, Dougherty, Barratt, Oderinde, 
Mathias, Harper, & Swann, 2002), and 
environmental (Hoaken et al., 2012; 
Moeller et al., 2002), to better 
understand causal pathways between 
drug use and aggressive behaviour. 
 
Sex differences in physical aggression 
are found early in childhood and are 
maintained through childhood into 
adulthood, mostly. A persistently 
aggressive group would typically 
contain a higher proportion of boys and 
a consistently non-aggressive group 
would normally contain a higher 
proportion of girls (Archer, 2012). This 
leads to implications that the early 
development of sex differences in 
aggression implies that they are not the 
result of socialization influences. The 
implication is that, although humans 
learn behaviours from society, 
differences in aggression could have 
innate properties. In their paper, Sex 
differences in Aggression: A Rejoinder 
and Reprise, Eleanor and Carol, (1980), 
discussed that evidence on the 
differential socialization of boys and 
girls support the view that boys do not 
receive more reinforcement for 
aggression than girls. 
 
Animal models of experimental and 
human studies have provided insight 
into the acute effects of drugs and 
psychoactive substances on aggressive 
behaviour. Some of the psychoactive, 
psychopharmacological or 
psychotropic drugs include alcohol, 
hallucinogens, and psychedelics, 
(cannabis, psilocybin, lysergic acid 
diethylamide), stimulants (cocaine, 
amphetamines, methamphetamines), 
opioids (morphine, codeine, heroin, 
tramadol), anabolic-androgenic 
steroids, designer drugs (bath salts, 
plant food), and depressants (ketamine, 
γ-hydroxybutyric acid or GHB). These 
substances may be used medically, 
recreationally, to purposefully improve 
performance or alter one’s 
consciousness or for research. Some of 
the numerous drugs and substances 
abused that usually have an effect on 
aggressive behaviour are opioids 
(tramadol and codeine).  
 
Tramadol 
Tramadol is an analgesic with opioid-
like effects when taken orally and a 
unique pharmacokinetic and 
pharmacodynamics profile relative to 
other opioids (Schnabel, Reichl, 
Meyer-FrieBem, Zahn, Pogatzki-Zahn, 
2015; Vlok, Melhuish, Chong, Ryan, 
&White, 2017). It is primarily 
prescribed to treat mild to severe pain 
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in both acute and chronic cases. When 
taken orally at high doses, tramadol 
may produce a euphoric sensation 
similar to oxycodone, when abused. 
Reported side effects of tramadol 
include itching, nausea, and 
constipation. Serious side effects 
include seizures, serotonin syndrome, 
decreased alertness, and dependence 
(Beakley, Kaye, &Kaye, 2015). It is 
available in the market as an immediate 
and extended-release formulation and 
used for the treatment of mild to severe 
pain at doses up to 200 (immediate) or 
300 (extended-release) milligrams per 
day. The World Health Organization 
(WHO) classification of Tramadol as a 
step 2 medication on its analgesic 
ladder makes it the only opioid 
classified as a step 2 medication, 
therefore, making it the only opioid-
like medication available for the 
management of moderate and severe 
pain in countries whose policies limit 
patient and provider access to step 3 
“strong” medications (Santos Garcia, 
Lech, Campos Kraychete, Rico, 
Hernandez-Castro, Colimon, 2017; 
Vijayan, Afshan, Bashir, Cardosa, 
Chadha & Chaudakshetrin, 2018). 
 
The first synthesis of Tramadol was in 
1962 and it became commercially 
available as an analgesic medication 
since 1977 (Grond, and Sablotzki, 
2004). Tramadol as a synthetic 
compound inhibits serotonin and 
norepinephrine reuptake before being 
converted through hepatic metabolism 
to active and inactive metabolites 
(Miotto, Cho, Khalil, Blanco, Sasaki, & 
Rawson, 2017). It is marketed as a 
hydrochloride salt and is available in a 
variety of pharmaceutical formulations 
for oral (tablets, capsules), sublingual 
(drops), intranasal (spray), rectal 
(suppositories), intravenous, 
subcutaneous, and intramuscular 
administration. It is also available in 
combination with acetaminophen 
(paracetamol), immediate-release and 
extended-release formulations. 
 
Continuous exposure to Tramadol like 
other opioids can lead to opioid 
physical dependence which can lead to 
withdrawal syndrome if exposure is 
subsequently discontinued (Lofwall, 
Walsh, Bigelow, & Strain, 2007). 
Unlike many other opioids, tramadol 
exerts effects on multiple 
neurotransmitter systems, including the 
opioid and also serotonin and 
norepinephrine systems. The effects of 
tramadol are only partially blocked by 
the opioid antagonist naloxone 
(Apaydin, 2000; Desmeules, 1996). 
Cross-tolerance with other opioids is 
minimal with tramadol, suggesting that 
its full profile of effects is a 
combination of its activities on opioid, 
serotonin and norepinephrine systems 
(Lofwall, Babalonis, Nuzzo, Siegel, 
Campbell, &Walsh, 2013; Dunn, 
Tompkins, Bigelow, & Strain, 2017; 
Lanier, Lofwall, Mintzer, Bigelow, & 
Strain, 2010).  
 
Tramadol is abused worldwide and its 
abuse is dependent on the regulatory 
status in  a particular country or region. 
Countries in which a wide variety of 
opioid products are available generally 
report low rates of tramadol abuse 
relative to other opioids while countries 
that impose greater restrictions on 
opioid products and rely more heavily 
on tramadol for primary pain 
management often report tramadol 
abuse (Radbruch, Glaeske, Grond, 
Munchberg, Scherbaum, & Storz, 
2013; Zosel, Bartelson, Bailey, 
Lowenstein, &Dart, 2013). According 
to Salm-Reifferscheidt (2018), the 
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abuse potential of tramadol in Egypt 
and other African countries was of 
particular concern, and there had been 
an observed increase in the importation 
of illicit and adulterated tramadol into 
these countries (Klein, 2019). 
Tramadol abuse among adolescents and 
young adults in those countries have 
been reported to be as high as 8.8% - 
12.3%, respectively (Bassiony, Salah 
El-Deen, Yousef, Raya, Abdel-Ghani, 
El-Gohari, 2015; Bassiony, 
Abdelghani,  Salah El-Deen, Hassan, 
El-Gohari, & Youssef, 2018). For 
instance, studies in Nigeria indicate the 
use of Tramadol cuts across all parts of 
the country. In Kano, Northern Nigeria, 
a cross-sectional study amongst 
commercial bus drivers reported that 
85.2% of respondents’ misuse 
Tramadol (Yunusa, Bello, Idris, 
Haddad, & Adamu, 2017). Another 
cross-sectional study among 
‘Almajiris’ (street children), in Borno 
Northern Nigeria, reported a 7% 
prevalence of Tramadol misuse 
(Abdulmalik, Omigbodun, Beida, & 
Adedokun,  2009). In Owerri, South-
East Nigeria, a survey of the use of 
psychoactive substances amongst 
university students indicated that 
53.4% admitted they use of Tramadol 
(Duru, Oluoha, Okafor, Diwe, & Iwu, 
2017). According to 39th WHO, 
ECDD Report, 2017, There is a 
widespread misconception regarding 
the use of tramadol among the general 
population with some viewing it as a 
mood enhancer, means to increase 
sexual stamina or as an energy booster 
during work. Individuals who abuse 
tramadol report that such mood-
elevating properties cause them to take 
higher doses of the drug or to take it 
more often than had been prescribed 
leading to abuse of tramadol, causing 
psychological or physical dependence 
and increasing the potential for 
overdose risks. 
 
Codeine 
Codeine is an alkaloid of phenanthrene 
and naturally occurring. It is an opioid 
agonist with analgesic, antidiarrheal 
and antitussive activities. Codeine 
extremely mimics the effects of 
Morphine as morphine is a major 
metabolite of codeine (Benini, Barbi,  
Gangemi, Manfredini, Messeri, & 
Papacci, 2010). Codeine binds with 
stereospecific receptors at many sites 
within the Central Nervous System 
(CNS) to alter processes affecting both 
the perception of pain and the 
emotional response to pain.  Precise 
sites and mechanisms of action have 
not been fully determined.  It has been 
proposed that there are multiple 
subtypes of opioid receptors, each 
mediating various therapeutic and/or 
side effects of opioid drugs.  Codeine 
has a very low affinity for opioid 
receptors and the analgesic effect of 
codeine may be due to its conversion to 
morphine (Gilman, Goodman, Rall, & 
Murad, 1985). 
 
Codeine is commercially available as 
water-soluble hydrochloride, sulfate or 
phosphate and is administered orally in 
the form of linctuses for the relief of 
coughs, and as tablets for the relief of 
pain.  Codeine phosphate is also given 
parenterally for the relief of pain. 
Codeine, usually as the phosphate, is 
often administered by mouth together 
with acetylsalicylic acid or 
paracetamol. The equivalence of the 
analgesic effects is 120 mg of codeine 
corresponds to 10 mg of morphine and 
30 mg of codeine to 325 to 600 mg of 
aspirin (Gilman, Rall, Nies, & Taylor, 
1990).  
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Codeine and codeine-containing 
products are among the drugs of abuse 
majorly by youths and young 
adolescents which has become a 
foremost emerging health challenge in 
various nations around the world. This 
might be attributed to the fact that the 
drugs are accessible in the range of 
over-the-counter (OTC) medications 
which are constantly bought without 
the need for a doctor’s prescription 
(Robinson, Robinson, McCarthy, & 
Cameron, 2010). According to a 
documentary titled “Sweet Sweet 
Codeine” released by British 
Broadcasting Corporation (BBC) in 
May 2018, thousands of youths in 
Nigeria, for instance, are addicted to 
codeine-containing products, especially 
the cough syrup formulation. This, 
however, led to the subsequent ban on 
the importation and sale of codeine as 
an active pharmaceutical ingredient 
(API) by the National Agency for Food 
and Drug Administration and Control 
(NAFDAC) in Nigeria (Washington 
Post, 2018). The ban on the importation 
and sale of codeine as an API has led to 
a drastic scarcity of codeine-containing 
products within the country, although, 
there is presently no legal backing on 
obtaining these products as a 
prescription-only medicine.  
 
Drug-Drug Interaction between 
Tramadol and Codeine 
Tramadol and codeine are both opiates. 
Codeine is made from the poppy plant, 
just like morphine, heroin, and opium. 
Tramadol is chemically similar to 
codeine, but it's synthesized from 
precursor molecules in a laboratory.  
Opiates work because the central 
nervous system has three main opioid 
receptors in the nerve cells that, when 
coupled with natural opioids help the 
body to govern pain sensation, reward, 
aspects of gastrointestinal function, 
aspects of respiratory function, and 
aspects of urogenital function. These 
receptors are named after Greek letters: 
Mu receptors, Delta receptors, and 
Kappa receptors. They sit on the 
membrane of nerve cells and activate 
when an opioid, whether naturally 
occurring in the body or introduced in 
the form of a drug, fits into the 
molecule like a key in a lock. Opiate 
drugs mimic the natural opioids 
produced by the body. Their molecules 
fit into the same receptors and activate 
them. Codeine, tramadol, morphine, 
and all other poppy derivatives target 
and activate mostly the Mu receptors, 
meaning they are "Mu receptor 
agonists" (Epstein, Preston, & Jasinski. 
2006). 
 
These receptors and the naturally 
occurring (endogenous) opioids they 
pair with are responsible for the body's 
own efforts to deaden the pain. 
Because of this, flooding the Mu 
receptors with pharmaceutical opioids 
like codeine, tramadol, and others can 
increase the painkilling (analgesic) 
properties of that part of the central 
nervous system. Unfortunately, 
because the endogenous opioid system 
also governs reward pathways, 
pharmaceutical opioids are highly 
addictive. Endorphins are the main 
endogenous opioids the nervous system 
secretes in response to sex, a delicious 
meal, and other forms of pleasure. 
Because opiate drugs activate the same 
Mu receptors endorphins do, euphoria 
and a profound sense of well-being are 
potential side effects of all the opiate 
drugs on the market. Patients can 
become addicted physically and 
mentally as both their bodies and minds 
begin to crave that state of bliss.  
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Research on tramadol and codeine 
relationship with aggressive behaviour 
is scanty even more scant than the 
research on other opioids and 
aggressive behaviour. This is an 
indication that researches on the link 
between opioids and aggression-
eliciting properties are scarce and 
perhaps poorly understood. Although 
past research has shown acute codeine 
administration (at a dose of 50 mg/70 
kg) to increase aggressive behaviour in 
a sample of young, healthy male 
participants after being provoked by a 
fake opponent (Spiga, Cherek, Roache, 
& Cowan,1990), further research is, 
therefore, needed to determine how 
other variables, such as sex or age, may 
moderate this relationship. Overall, 
there is no evidence to support a direct 
pharmacological relationship between 
opioid use and aggression, although 
third variable factors may contribute to 
the relationship between heroin use and 
increased aggression in some cases.  
 
Purpose of Study 
This research is, therefore, aimed at 
mainly, to experimentally examine the 
effects of separate and combined 
chronic administration of the opioids, 
Codeine and Tramadol on the 
aggressive behaviour of female albino 
rats, and specifically to; 
• examine the effects of chronic 
Codeine administration on 
aggressive behaviour among female 
albino rats. 
• examine the effects of chronic 
Tramadol administration on 
aggressive behaviour among female 
albino rats. 
• examine the effects of the combined 
acute administration of both 
Codeine and Tramadol on 
aggressive behaviour among female 
albino rats. 
• determine which drug elicits higher 
or lower aggression levels in female 
albino rats in comparison to the 
other drug. 
Hypotheses 
In determining the relationship between 
the chronic administration of drugs 
(codeine and tramadol) and aggressive 
behaviour in female albino rats, the 
following hypotheses were formulated 
and tested.  
1. Chronic exposure to Tramadol and 
Codeine will significantly affect 
the aggressive behaviour of female 
albino rats exposed to the drugs.  
2. Female albino rats exposed to 
tramadol will display more 
aggressive behaviour than female 
albino rats exposed to codeine.  
3. Tramadol and Codeine will singly 
and jointly interact to affect the 
aggressive behaviour of female 
albino rats exposed to chronic 
administration of the drugs.  
 
Methodology 
Research design 
The design used in this study is an 
independent group randomized design. 
Participants in the study were selected 
and placed in four different groups. 
The first group was administered 
Codeine, the second was administered 
Tramadol, the third group was 
administered both drugs, Codeine and 
Tramadol and the fourth group was the 
control group. The independent 
variables are the chronic administration 
of Codeine, Tramadol, and the 
combination of both to the female 
albino rats. The dependent variable is 
aggressive behaviour displayed or 
exhibited by the female albino rats. 
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Setting 
The experiment took place at the 
Animal Science Laboratory, University 
of Ibadan, Oyo State, Nigeria. 
 
Animal Population 
The animals used were female Albino 
rats. A total of 28 female Albino rats 
weighing between 120 -150g and 4 – 6 
weeks old were used. They were 
divided into five (5) groups with six (6) 
female rats in each group except the 
fifth group which had only four rats. 
The groups were Codeine group, 
Tramadol group, combined Codeine 
and Tramadol group, control group, 
and the intruder group with four (4) 
rats used as intruder rats in the 
aggression experiment. The rats were 
randomly assigned to the different 
groups.  
 
Drugs 
The drugs used for this study were 
Tramadol HCL (50 mg capsules) and 
Cough syrup (containing 220mg 
codeine). Codeine and Tramadol were 
administered orally with the use of an 
oral cannula. The rats were given 
20mg/kg bodyweight of Tramadol  
following the recommended 5mg/kg – 
20mg/kg dose for oral administration 
of tramadol in rats (Rat Medication 
Guide, 2010), while Codeine was 
administered at a dose of 8mg/kg body 
weight every 24 hours  following the 
recommended therapeutic dose of 
2mg/kg/6hrs (Achukwu, Omorodion, 
Erabor, Aloh, Eze & Okoyeocha, 
2019). The dosage administered in this 
study was, Codeine- 8 mg/kg and 
Tramadol- 20mg/kg. 
 
Materials/Instruments 
The following materials and 
instruments were used for this study; 
1. 6 experimental rat cages.  
2. Recording sheets 
3. Distilled water/saline 
4. Laboratory coat 
5. Oral cannula for administration of 
drugs  
6. Hand Gloves. 
7. Face/Nose Mask 
8. Colored markers for easy 
identification of female albino 
rats from, the control and 
experimental rat. 
9.  Measuring cylinders used in 
diluting and measuring the 
solution. 
10. Weighing balance for the daily 
weighing of rats.  
11. Stopwatch for time keeping and 
recording  
12. Disposable syringes  
13. Mouse cubes for feeding the rat  
14. Codeine syrup 
15. Tramadol capsules (powder in 
capsule serially diluted with 
distilled water) 
 
Procedure 
Two weeks before the commencement 
of experiments, the rats were brought 
into the laboratory and left to 
acclimatize in the laboratory. During 
this period, the rats were provided with 
food and water without any form of 
deprivation. The rats were then 
randomly assigned into 5 groups, the 
Codeine group, the tramadol group, the 
Combined group, the Control group, 
and the intruder group. 
 
The study took 28 days, in which the 
rats in the experimental group were 
exposed to the drugs (oral ingestion of 
the drugs). Each cage was clearly 
labelled with the drug category. Rats 
were also marked for identification and 
rats in each cage were labelled 1 to 6. 
The resident-intruder paradigm was 
used. It is a method of studying or 
observing aggressive behaviour which 
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introduces an intruder rat to the 
resident rat. 
 
At the start of the experiment each day, 
all the rats were weighed and records 
of the weights against each rat were 
kept in a chart. This is to determine 
what dose of drugs to administer to 
each rat daily. After the drug 
administration, the rats were allowed 
30 minutes before the commencement 
of data collection to give enough time 
for the onset of drug action. During the 
first 30 minutes of post-drug 
administration, food and water were 
withdrawn from all the cages.  
 
After the 30 minutes of post-drug 
administration, one rat from the 
experimental group was placed in a 
free experimental cage and an intruder 
rat was introduced. The behaviour of 
the resident rat was observed and data 
was collected. Each experimental 
session lasted for 5 minutes during 
which observations for aggressive 
behaviour for each rat were made. The 
attributes of aggression observed were 
dominant posture, scratching, and 
biting. These behaviours were recorded 
with a recording sheet marking the 
number of times the experimental rat 
exhibited any of the behaviours. After 
5 minutes, both the experimental rat 
and the intruder rat were removed from 
the experimental cage and returned to 
their respective cages. The process was 
repeated for all the remaining rats in all 
of the experimental groups of Codeine, 
Tramadol, Combined Codeine and 
Tramadol, and then the control group. 
This same procedure of observation 
was repeated for three trials for each rat 
daily for the 28-day duration of the 
experiment. 
 
On each day of the experiment, the 
following including regular feeding 
was carried out: 
- Weighing of each rat 
- Oral administration of drugs 
- Observation of the dominant 
postures, scratching, and biting. 
At the end of the experiment, all the 
rats were discarded following the 
procedures recommended for disposal 
of animals used for research purposes 
by the cruelty to animal act. 
 
Statistical analysis 
All results were analyzed using one-
way ANOVA. Any P value less than 
0.05 was considered 
 
Results 
The results of the study on the effect of 
chronic administration of tramadol and 
codeine on the aggressive behaviour of 
female Albino rats are presented. The 
data collected were subjected to 
Randomized Block Analysis of 
Variance (ANOVA), descriptive 
statistics of mean and standard 
deviation as well as a graphical 
representation.
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Table 1: Summary Randomized block ANOVA Table showing the effect of 
administration of Tramadol and Codeine on aggressive behaviour of female albino rats.  
Source 
Type III Sum of 
Squares Df Mean Square F Sig. Partial η2 
Block 7737.128 2 3868.564 53.354 .000 .050 
Treatment 11643.557 3 3881.186 53.528 .000 .074 
Error 145739.453 2010 72.507    
Corrected Total 165120.138 2015     
 
The result from Table 1 shows that 
Tramadol and Codeine significantly 
affected the aggressive behaviour 
among the female albino rats. F 
(3,2010) = 53.53, p < 0.001, η2= .07. 
The result demonstrated that aggressive 
behaviour increased by 7% with the 
intake of the psychoactive substances. 
 
Table 2: Summary Bonferonni mean comparison analysis showing the mean difference between 
aggressive behaviour of female albino rats ingested with different drugs.  
 Mean  S.E.M 1 2 3 4 
CODEINE 11.413 .379 - 4.046* -.113 -2.669* 
COMBINED 7.367 .379  - -4.16* -6.71* 
CONTROL 11.526 .379   -- -2.56* 
TRAMADOL 14.081 .379    - 
*. The mean difference is significant at the .05 level.  
b. Adjustment for multiple comparisons: Bonferroni. 
 
From the analysis, mean differences 
showed that female albino rats in the 
tramadol treatment group (  14.08) 
and control group ( 11.53) 
significantly exhibited more aggressive 
behaviour compared to rats in the 
codeine ( 11.41) and combined 
group ( 7.36). The mean differences 
were significant (p<.001). 
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Fig. 1: line graph showing the effect of drugs ingested on aggressive behaviour 
 
Female albino rats in the Tramadol 
treatment group and control group were 
shown to exhibit more aggressive 
behaviour compared to rats in the 
codeine and combined group. 
Based on this, the hypothesis that states 
that there would be a significant 
difference in the aggressive behaviour 
of female albino rats ingested with 
different drugs.  is accepted. 
 
 
Fig 2: Interaction graph showing the interaction between time of exposure and treatment to 
chronic intake of psychoactive drugs on aggressive behaviour (Codeine& Tramadol) among 
Wister rats.  
 
The line graph shows how the effects 
of a long period of exposure to chronic 
intake of psychoactive drugs (Codeine 
& Tramadol) on rats was evident from 
the 14th – 28th days of the exposure. 
Rats ingested with drugs displayed 
lower aggression levels when 
compared with the control group. Rats 
ingested with tramadol exhibited more 
aggressive behaviour when compared 
to that of the codeine and combined 
group.  
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Discussion  
The findings of this study show the 
significant effect of the link between 
Codeine and Tramadol on the 
aggressive behaviour of female albino 
rats. The hypothesis which stated that 
chronic exposure to Tramadol and 
Codeine will significantly affect the 
aggressive behaviour of female albino 
rats exposed to the drugs  was thus 
validated. 
The administration of tramadol and 
codeine on the rats significantly 
increased the aggressive behaviour of 
the rats by about 7%. The group with 
the highest aggression mean was the 
tramadol group with 14.08, the control 
group with 11.53, the codeine group 
with 11.41, and the combined group 
with 7.37. 
The results of this study show that the 
tramadol group displayed the highest 
level of aggression compared to all the 
other groups. The tramadol group was 
observed during the experiment to be 
very jumpy, easily agitated and very 
swift to attempt to inflict harm on the 
intruder rats when compared to the rats 
in other groups. There are indications 
that Tramadol is unique and may be 
different from other opiates laying 
some doubts about the erroneous belief 
that tramadol may not be as harmless 
as we are popularly led to believe. 
Researches show that tramadol is a 
complex synthetic opiate, which has 
actions on multiple neurotransmitters 
and receptors over and above other 
opioids. It is a serotonin releasing 
agent, a noradrenaline reuptake 
inhibitor (Serotonin-norepinephrine 
reuptake inhibitor-SNRI), and an 
NMDA receptor (BMJ, 2013). They 
affect two important brain chemicals, 
serotonin, and norepinephrine an 
indication that the physical withdrawal 
symptoms may not be as severe as 
other opiates. Tramadol acts in a way 
to inhibit the reuptake of serotonin and 
norepinephrine, thus increasing the 
amount of both neurotransmitters in the 
system (Spies, Swart, van der Zanden, 
de Rooij, van Munster, 2017). These 
neurotransmitters are responsible for 
mood and their increase may lead to 
the increased activity observed in the 
tramadol group. The symptoms that 
accompany the use of tramadol are 
very severe and distressing for the 
individual that uses it. These symptoms 
include aggression and insomnia, 
severe anxiety, increased heart rate, 
depression, hyperactivity, serotonin 
syndrome, respiratory depression, and 
liver failure (Duke, Bigelow, Lanier, 
&Strain, 2011). It also possesses a 
marked ability to induce seizures 
leading to the death of the victim. 
Report of symptoms identical to those 
of serotonin syndrome (symptoms 
include high body temperature, 
agitation, increased reflexes, tremor, 
sweating, dilated pupils, and 
diarrhoea), were present in this study. 
Serotonin syndrome is a serious 
condition caused by excess 
serotonergic activity and characterized 
by altered mental status and heightened 
neuromuscular and autonomic activity 
(Junji, & Mark, 2009). This may 
explain why the rats in the tramadol 
group were relatively more active than 
the rats in the other drug groups.  
Codeine, on the other hand, is a drug 
that is most commonly abused for its 
calming effects. Results from this study 
show that the aggression in the codeine 
group was very low and is only slightly 
higher than the least aggressive group, 
the combined group. During the 
experiment, the rats in this group 
appeared to be relatively less active 
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than other groups except for the 
combined group. They were observed 
to exhibit drowsiness, shakiness, and 
weakness leading to inactivity and 
were not eating as much as rats in the 
other groups except the combined 
group. Codeine is known to have a 
higher analgesic activity than tramadol 
and produces more euphoric effects on 
the body system (Benini et al., 2010). 
Codeine is an analgesics agent that 
selectively relieves pain by acting in 
the Central Nervous System without 
changing consciousness. Its higher 
analgesic activity suggests that it is 
stronger than tramadol and hence 
further depresses the system in more 
ways than tramadol could. This makes 
the reactions to this opioid more 
adverse and included drowsiness, 
sedation, and shortness of breath as 
observed in the experimental rats in the 
codeine group.   Concerning 
aggression, the codeine group 
displayed way less aggression than the 
tramadol group. The causal factors may 
be linked to the identified higher 
analgesic property that codeine has 
over tramadol. 
 The results show that female rats in the 
combined group of Tramadol and 
Codeine exhibited the lowest level of 
aggression with a mean difference of 
4.0 when compared to the codeine 
group and 6.7 when compared with the 
tramadol group. Rats treated with the 
combination of codeine and tramadol 
had the effects of both opioids working 
in them simultaneously, leading to a 
stronger force of analgesic activity on 
them. They were the least aggressive as 
they had combined strength of two 
depressants at work on their body 
system. Both tramadol and codeine 
cause respiratory depression. 
Respiratory depression or 
hypoventilation is a breathing disorder 
characterized by slow and ineffective 
breathing. The combination of opioids 
and central nervous system depressants 
had an additive effect on the 
oversedation and respiratory depression 
of the female albino rats in this group. 
Respiratory depression is a potentially 
lethal complication that occurs when 
opioids are used in combination with 
other opioids or depressants. The rats 
in the codeine and tramadol 
(combined) treatment group 
experienced higher sedation, were 
quick to assume a subdued position 
when faced with an intruder rat, greatly 
reduced weight gain, lessened self-
grooming practices, slowed down 
physical activity and eventually death 
of four out of six rats in the group. 
Other physical defects observed in the 
rats of the combined group throughout 
the experiment were extreme weight 
loss, observable discomfort in hind 
limb(s), bloodshot eyes, bleeding nose, 
inactivity for several hours even when 
faced with an intruder rat, loss of 
appetite, shakiness, dizziness, and 
drowsiness. The average weight of the 
rats in the combined group dropped by 
34% at the end of the experiment. 
Conclusion 
The opioids, Codeine, and tramadol are 
drugs that reduce the perception of pain 
felt by an individual, = resulting in a 
relaxed, euphoric feeling. This feeling 
should, therefore, reduce the chance 
that one will display aggression when 
the drug is administered, which was 
observed to be very true for codeine 
and also in combination with tramadol. 
However, prolonged use of tramadol 
usually leads to an excess of 
serotonergic activity, known as 
serotonin syndrome. This results in 
increased alertness, jerky movements, 
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paranoia, which could all be 
contributing factors to aggressive 
behaviours.  
It has been concluded, therefore, from 
this study that the chronic intake of 
Codeine reduces aggressive behaviour. 
Although the symptoms associated 
with tramadol and codeine are quite 
non-identical (the former including 
feelings of agitation or restlessness; 
and the latter including drowsiness), 
this study has shown that they have 
similar neurological effects on 
aggressive behaviour. Prolonged intake 
of one or both of the drugs can cause 
nearly irreversible damage to the 
nervous system. A lot of times, death is 
the effect of the combined intake of the 
drugs as observed among the rats used 
for this study. Tramadol, on the one 
hand, creates a state of restlessness and 
agitation in users which could translate 
to aggressive behaviours in certain 
situations. Codeine, on the other hand, 
creates a state of drowsy and relatively 
inactive disposition on the users. 
Awareness of the serotonergic effects 
of tramadol is important in avoiding 
potential side effects and unwelcome 
interactions with other medications. 
Combining codeine and tramadol is 
dangerous because their combined 
effects on the Central Nervous system 
can increase dramatically and can lead 
to accidental overdoses. While this 
might not seem to have any 
relationship with aggression, we can 
only assume or infer that a person who 
is sick, nearly to the point of death 
would not be strong enough to be 
aggressive.  
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